Data Foundry

Drug recalls 2026

Fosfomycin Tromethamine Granules for Oral Solution — Class II drug recall D-0014-2027

Ongoing recall by Cipla USA, Inc., reported 2026-10-14, distributed nationwide. Failed Impurities/Degradation Specifications

Recall numberD-0014-2027
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmCipla USA, Inc., Warren, NJ, United States
Recall initiated2026-09-18
Classified2026-10-06
Reported by FDA2026-10-14
DistributedNationwide (US)
Reason classesspecification failure
NDC69097-0579, 69097-0579-67
Lot numbers5KA0405
Expiration dates2026-12-31

Product

Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx only, Manufactured by: Cipla Ltd., Kurkumbh-413802, Maharashtra, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-579-67.

Reason for recall

Failed Impurities/Degradation Specifications

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0014-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-10-21. Not affiliated with or endorsed by FDA. Not medical or legal advice.